Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study

This study was performed to assess the efficacy and safety of preoperative chemoradiation consisting of carboplatin and paclitaxel and concurrent radiotherapy for patients with resectable (T2-3N0-1M0) oesophageal cancer. Treatment consisted of paclitaxel 50 mg m(−2) and carboplatin AUC=2 on days 1,...

Descripción completa

Detalles Bibliográficos
Autores principales: van Meerten, E, Muller, K, Tilanus, H W, Siersema, P D, Eijkenboom, W M H, van Dekken, H, Tran, T C K, van der Gaast, A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361286/
https://www.ncbi.nlm.nih.gov/pubmed/16670722
http://dx.doi.org/10.1038/sj.bjc.6603134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361286/
https://www.ncbi.nlm.nih.gov/pubmed/16670722
http://dx.doi.org/10.1038/sj.bjc.6603134

Ejemplares similares